AntineoplasticsExanthema, rash and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1935卷 / 1期

关键词：

D O I：

10.1007/s40278-022-28854-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：59 / 59

相关论文

共 50 条

[1] CondoliaseSkin rash and lack of efficacy: case report
Reactions Weekly, 2022, 1918 (1) : 158 - 158
[2] ModafinilHaemorrhagic rash and lack of efficacy: case report
Reactions Weekly, 2019, 1776 (1) : 299 - 299
[3] NiacinUrticarial rash and lack of efficacy : case report
Reactions Weekly, 2024, 2020 (1) : 362 - 362
[4] AntineoplasticsShock, rash and lack of efficacy: case report
Reactions Weekly, 2023, 1949 (1) : 63 - 63
[5] Amiodarone/lidocaineUrticarial rash and lack of efficacy: case report
Reactions Weekly, 2022, 1934 (1) : 23 - 23
[6] TepotinibOedema, maculopapular rash and lack of efficacy: case report
Reactions Weekly, 2025, 2043 (1) : 368 - 368
[7] Methotrexate/tirabrutinibMaculopapular rash and lack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 279 - 279
[8] Ampicillin/sulbactamErythematous rash and lack of efficacy: case report
Reactions Weekly, 2022, 1933 (1) : 41 - 41
[9] Multiple drugsDrug rash and lack of efficacy : case report
Reactions Weekly, 2023, 1980 (1) : 261 - 261
[10] AntibioticsGeneralised maculopapular rash and lack of efficacy: case report
Reactions Weekly, 2025, 2049 (1) : 36 - 36

← 1 2 3 4 5 →